Learn more about what Meitheal Pharmaceuticals is doing to deliver on its vision of Healthcare Solutions within reach.

Watch Video

Our Brands

Meitheal Pharmaceuticals is committed to helping solve unmet needs by being focused within the biopharma industry on products that make a difference. Our dedication to this goal is demonstrated through our development pipeline and initiatives including recent acquisitions of YUSIMRY® and CONTEPO™ (pending FDA approval) that will have a positive impact on patient care.


This chimeric human-murine anti-tumor necrosis factor α (TNFα) is being developed as a novel biologic product specifically for the treatment of sarcoidosis. The monoclonal antibody targets the inflammatory response known to occur in patients living with this rare disease. TNFα is a pro-inflammatory cytokine released by immune cells that may promote the formation of harmful granulomas and fibrosis throughout the body of people with the condition. To date, strong early data supports this lead candidate as a potential next-generation treatment for this chronic, multisystem inflammatory disorder.

More About XTMAB-16


MAI-25 is an investigational, first-in-class intravenous (IV) epoxide antibiotic with a broad spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains that threaten hospitalized patients. Fosfomycin IV has an extensive history from markets outside the U.S., where it has been utilized for over 45 years in nine indications. CONTEPO™ utilizes a new dosing approach, to optimize the compound’s pharmacokinetics and pharmacodynamics.

Our Pipeline


Drug Name Therapeutic Area Type Discovery Preclinical Phase 1 Phase 2 Phase 3 Submission
XTMAB-16 Sarcoidosis Biologic
MHAI-25 Anti-Infective Small Molecule
You might also be interested

The brands mentioned here are the trademarks of their respective owners.

This Website Uses Cookies

This website uses cookies to help give you the best experience when you visit. By clicking “Accept Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and help us make improvements to our site. You can read more about our use of cookies in our Privacy Policy.

Manage Consent Preferences

Always Active

Necessary cookies enable core functionality such as security and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

These cookies are set to provide quantitative measures of website visitors. Information collected with these cookies is used in operations to measure website performance. With the usage of these cookies we are able to count visits and traffic sources to improve our site. The data is collected in a way that does not directly identify anyone.
Accept all cookies Confirm my choices